Sign up now for ease of access to The Medical Independent, Ireland’s most frequently published medical newspaper, delivering award-winning news and investigative reporting.

  • receive the eCopy two days prior to the printed edition.
  • can partake in our online MCQs.
  • can enter our online sports quiz.


Medicalindependent.ie is Ireland's only investigative medical news website for doctors, healthcare professionals and anyone with an interest in health issues.

Established in 2010, along with its sister publication The Medical Independent, our stated aim is to investigate and analyse the major issues affecting healthcare and the medical profession in Ireland. The Medical Independent has won a number of awards for its investigative journalism, and its stories are frequently picked up by national digital, broadcast and print media. The Medical Independent is published by GreenCross Publishing.

Address: Top Floor, 111 Rathmines Road Lr, Dublin 6

Tel: 353 (01) 441 0024

GreenCross Publishing is owned by Graham Cooke.

Drug candidate shows potential to stop progression of sepsis

By Mindo - 25th Mar 2019 | 41 views

Research into a new breakthrough therapy for sepsis has shown it has potential to stop sepsis-causing bacteria from triggering organ damage in the early stages of the condition. The pre-clinical trial of InnovoSep, carried out by researchers at RCSI, has demonstrated that the drug also has the potential to stop progression of sepsis to multiple organ failure in the later stages. The research was presented at the recent RCSI Research Day 2019 by Dr Sinéad Hurley, a Postdoctoral Fellow at the School of Pharmacy and Irish Centre for Vascular Biology.
Pictured with Dr Hurley is Principal Investigator Prof Steve Kerrigan, Associate Professor of Pharmacology in the School of Pharmacy and Head of the Cardiovascular Infection Research Group at the Irish Centre for Vascular Biology.

Leave a Reply

Latest
Latest Issue
medical news
The Medical Independent 19th May 2022

You need to be logged in to access this content. Please login or sign up using the links below.

Most Read